The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition

The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition
NOW IN ITS TENTH EDITION!

While tests run on lab-based analyzers in hospitals and reference labs remain the bedrock of IVD revenues, point of care has always been seen as the growth area. For as long as Kalorama Information has covered point of care diagnostics, and this now spans 2 decades, point of care tests are the opportunity area. Point of care as implied in the name is defined as tests that can be meaningful in a provider visit, or in the patients home.

How can diagnostics promote wellness? How can diagnostics improve patient-provider encounters? How can tests promote better selection and stewardship of drugs? How can tests facilitate patient home or nursing home of the future? How can diagnostics ensure the next pandemic, if and when it arrives is appropriately handled? The answers to these questions in many ways rely on the success of point-of-care solutions.

And because of this contribution, Point of Care diagnostics can earn a higher pricing and larger revenue growth than economized lab-based tests. The tests covered in this report tend to grow at higher rates than overall IVD market.

Enhanced Segmentation - Many Reports in One

Here are just some of the areas covered in this report Glucose Coagulation CRP Other Cardiac Markers Coagulation Colon Cancer Pregnancy / Fertility Drugs of Abuse hbA1c Cholesterol HIV COVID-19 Other Infectious Disease Critical Care TestsThese are detailed with market sizing and forecast in this report.

As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. 
Venue Market Analysis
POC tests are performed in a wide range of geographical locations such as: Hospital departments such as emergency departments, operating rooms, intensive care units, and others Physicians’ offices Hospital clinics Retail clinics Pharmacies Homes – With testing performed by patients, visiting nurses, or other caregivers Nursing homesPOC testing may be performed by laboratory personnel, but often it is performed by non-laboratory personnel such as physicians, nurses, assistants in medical offices, emergency medical technicians (EMTs), medics, pharmacists, and the patients themselves (self-testing). Some POC tests are manual tests, often performed with technologies based on dipsticks or strips, lateral flow cassettes, or other manual tests. There are also many small, portable instruments that have been developed for use in POC settings. With the advances in miniaturization and microfluidics that have occurred in recent years, a growing number of small, handheld devices are reaching the POC market for a range of different testing applications.

Regional Coverage

POC is an international market and Kalorama reflects this with regional coverage.

Analysis is anchored by: Europe Japan United States Rest of WorldHowever other countries and regions discussed in the report include: Australia Canada China France Germany India Italy South Korea Spain Sweden Switzerland Latin America Middle EastCorporate Profiles

Moreover, POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. More diagnostic manufacturers have pursued CLIA waiver status for their POC devices and CE Mark for POC or self-use. At the same time, more decentralized test venues invest in non-waived rapid tests and instruments. POC testing appears to be headed for an even bigger role in diagnosis and monitoring patient care. New technologies are allowing POC devices to produce quantitative lab-quality test results that can be transferred automatically to an information system, a remote caregiver service for consultation or an electronic medical record. Rapid tests are beginning to fold into the point of care arena because they allow the physician to treat the patient before they leave the clinic or office.

This report breaks out point of care testing by segment.

Among the top and/or innovative competitors discussed within Corporate Profiles are: 1 Step Detect Associates, Llc Abbott Laboratories Abingdon Health Ltd. Accessbio, Inc. Accubiotech Co, Ltd. Acon Laboratories, Inc Aerscher Diagnostics, Llc Alfa Scientific Designs, Inc American Bio Medica Corporation Arkray, Inc. Artron Laboratories, Inc Ascensia Diabetes Care Holdings Ag Atlas Link Biotech Co., Ltd Autobio Diagnostics Co., Ltd Beckman Coulter, Inc Becton Dickinson (Bd) Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Bhat Bio-Tech India Private Ltd. (Bbi) Binx Health Biolytical Laboratories Biomedomics, Inc Biomeme, Inc Biomerica, Inc. Biomerieux Sa Bio-Rad Laboratories Inc. Biosensia Ltd. Biotron Diagnostics, Inc. Boditech Med Inc Boson Biotech Co. Ltd Btnx Inc. Calypte Biomedical Corporation Cepheid, Inc Chembio Diagnostics, Inc. Church & Dwight Co. Inc Clarity Diagnostics, Llc Confirm Biosciences Ctk Biotech, Inc. Cue Health Danaher Corporation Dexcom, Inc Dialab Gmbh Diasys Diagnostic Systems Gmbh Diazyme Laboratories, Inc. Dna Electronics Ltd. (Dnae) Dr. Fooke-Achterrath Laboratorien Gmbh Dxgen Corp. Eiken Chemical Co Ltd. Ekf Diagnostics Holdings Plc Elitechgroup S.A.S. Enterix, Inc. (Clinical Genomics) Eurobio Scientific Everlywell Exact Sciences Ey Laboratories First Check Diagnostics Llc Genbio Genedrive Plc Getein Biotech Inc. Glysby Diagnostics Helena Laboratories Hemosure, Inc. Horiba, Ltd. Immune Iq Immunosciences Lab, Inc. Immunostics, Inc Jal Innovation Pte Ltd Jant Pharmacal Corporation J. Mitra & Co Pvt. Ltd Lamdagen Corporation Lifescan, Inc Lifesign, Llc Lightdeck Diagnostics Lumiradx Uk Limited Macherey-Nagel Gmbh & Co. Kg Medix Biochemica Medmira, Inc Medtronic, Inc. Menarini Diagnostics Srl. Meridian Bioscience, Inc Mico Biomed Usa Nano-Ditech Corporation Ng Biotech Noble Medical, Inc Nova Biomedical Corp. Oasis Diagnostics Corporation Operon S.A. Opko Health, Inc Orasure Technologies, Inc. Polymedco, Inc Polymer Technologies, Inc (Pts Diagnostics) Preventis Gmbh Princeton Biomeditech Corporation Quantumdx Group Limited Quidelortho Corporation Radiometer Medical A/S Randox Laboratories Limited Response Biomedical Corp Reszon Diagnostics International Sdn. Bhd. Rheonix, Inc Roche Diagnostic Corporation Savyon Diagnostics Sekisui Diagnostics Llc Siemens Healthineers Gmbh Sysmex Corporation Techlab, Inc. Trinity Biotech Plc Trividia Health Tulip Diagnostics Ltd (Tulip Group) Vedalab Veredus Laboratories Pte Ltd WerfenScope and Methodology

The geographic scope of The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 10th Edition is global, with information for specific geographical regions, world demographics, and other general issues affecting the market. The market summary includes total market values, market analysis by product, test usage, technology, region, end-use and a competitive analysis of leading providers. Additionally, key company profiles are included.

All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests excluding services. The base year for data was 2022, including updates and reexaminations stemming from the impact of the COVID-19 pandemic. Forecast data is provided for 2022 through 2026. Compound annual growth rates (CAGRs) are provided for 2022-2026 periods for each segment covered. Competitive analysis is provided for the year 2022 along with regional breakdowns. The forecasted market analysis for 2022-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.